E2a/Pbx1 Induces the Rapid Proliferation of Stem Cell Factor-Dependent Murine Pro-T Cells That Cause Acute T-Lymphoid or Myeloid Leukemias in Mice

Molecular and Cellular Biology

Volumn 24, Issue 3, 2004, Pages 1256-1269

  Sykes, David B ^a   Kamps, Mark P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYTOKINE; ONCOPROTEIN; ONCOPROTEIN E2A; STEM CELL FACTOR; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA BINDING; MOUSE; MYELOID LEUKEMIA; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOBLAST; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; CELL DIVISION; DNA-BINDING PROTEINS; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; LEUKEMIA, MYELOID; LYMPHOID ENHANCER-BINDING FACTOR 1; MEMBRANE PROTEINS; MICE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; REPRESSOR PROTEINS; STEM CELL FACTOR; THYMUS GLAND; TRANSCRIPTION FACTORS;

ANIMALIA; MURINAE;

EID: 1642580761     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.3.1256-1269.2004     Document Type: Article

References (50)

1. Akashi, K., D. Traver, T. Miyamoto, and I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-197.
2. Badiani, P., P. Corbella, D. Kioussis, J. Marvel, and K. Weston. 1994. Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev. 8:770-782.
3. Bain, G., I. Engel, E. C. Robanus Maandag, H. P. te Riele, J. R. Voland, L. L. Sharp, J. Chun, B. Huey, D. Pinkel, and C. Murre. 1997. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:4782-4791.
4. Bayly, R., and D. P. LeBrun. 2000. Role for homodimerization in growth deregulation by E2a fusion proteins. Mol. Cell. Biol. 20:5789-5796.
5. Calvo, K. R., P. Knoepfler, S. McGrath, and M. P. Kamps. 1999. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene 18:8033-8043.
6. Calvo, K. R., P. S. Knoepfler, D. B. Sykes, M. P. Pasillas, and M. P. Kamps. 2001. Meisla suppresses differentiation by granulocyte colony-stimulating factor and promotes proliferation by SCF: Potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc. Natl. Acad. Sci. 98:13120-13125.
7. Calvo, K. R., D. B. Sykes, M. P. Pasillas, and M. P. Kamps. 2002. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7, and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral coexpression of Hoxa9 and Meis1. Oncogene 21:4247-4256.
8. Carleton, M., N. R. Ruetsch, M. A. Berger, M. Rhodes, S. Kaptik, and D. L. Wiest. 1999. Signals transduced by CD3epsilon, but not by surface pre-T-cell receptor complexes, are able to induce maturation of an early thymic lymphoma in vitro. J. Immunol. 163:2576-2585.
9. Carroll, A. J., W. M. Crist, R. T. Parmley, M. Roper, M. D. Cooper, and W. H. Finley. 1984. Pre-B-cell leukemia associated with chromosome translocation 1;19. Blood 63:721-724.
10. Chervinsky, D. S., X. F. Zhao, D. H. Lam, M. Ellsworth, K. W. Gross, and P. D. Aplan. 1999. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol. Cell. Biol. 19:5025-5035.
11. Dedera, D. A., E. K. Waller, D. P. LeBrun, A. Sen-Majumdar, M. E. Stevens, G. S. Barsh, and M. L. Cleary. 1993. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74:833-843. (Erratum, 75:826.)
12. Deftos, M. L., E. Huang, E. W. Ojala, K. A. Forbush, and M. J. Bevan. 2000. Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity 13:73-84.
13. Devaraj, P. E., L. Foroni, V. Kitra-Roussos, and L. M. Secker-Walker. 1995. Detection of BCR-ABL and E2A-PBX1 fusion genes by RT-PCR in acute lymphoblastic leukaemia with failed or normal cytogenetics. Br. J. Haematol. 89:349-355.
14. Engel, I., C. Johns, G. Bain, R. R. Rivera, and C. Murre. 2001. Early thymocyte development is regulated by modulation of E2A protein activity. J. Exp. Med. 194:733-745.
15. Georgopoulos, K., M. Bigby, J. H. Wang, A. Molnar, P. Wu, S. Winandy, and A. Sharpe. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143-156.
16. Godfrey, D. I., J. Kennedy, T. Suda, and A. Zlotnik. 1993. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150:4244-4252.
17. Godfrey, D. I., A. Zlotnik, and T. Suda. 1992. Phenotypic and functional characterization of c-kit expression during intrathymic T-cell development. J. Immunol. 149:2281-2285.
18. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
19. Herblot, S., A. M. Steff, P. Hugo, P. D. Aplan, and T. Hoang. 2000. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Nat. Immunol. 1:138-144.
20. Ikawa, T., S. Fujimoto, H. Kawamoto, Y. Katsura, and Y. Yokota. 2001. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. 98:5164-5169.
21. Kamps, M. P., and D. Baltimore. 1993. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphoblastic leukemia, causes acute myeloid leukemia in mice. Mol. Cell. Biol. 13:351-357.
22. Kamps, M. P., and D. D. Wright. 1994. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene 9:3159-3166.
23. Kamps, M. P., D. D. Wright, and Q. Lu. 1996. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene 12:19-30.
24. Katsura, Y. 2002. Redefinition of lymphoid progenitors. Nat. Rev. Immunol. 2:127-132.
25. Kawagoe, H., R. K. Humphries, A. Blair, H. J. Sutherland, and D. E. Hogge. 1999. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia 13:687-698.
26. King, A. G., M. Kondo, D. C. Scherer, and I. L. Weissman. 2002. Lineage infidelity in myeloid cells with T-cell receptor gene rearrangement: A latent developmental potential of pro-T cells revealed by ectopic cytokine receptor signaling. Proc. Natl. Acad. Sci. 99:4508-4513.
27. Kondo, M., D. C. Scherer, T. Miyamoto, A. G. King, K. Akashi, K. Sugamura, and I. L. Weissman. 2000. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407:383-386.
28. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-672.
29. Larson, R. C., I. Lavenir, T. A. Larson, R. Baer, A. J. Warren, I. Wadman, K. Nottage, and T. H. Rabbitts. 1996. Protein dimerization between Lmo2 (Rbtn2) and Tall alters thymocyte development and potentiates T-cell tumorigenesis in transgenic mice. EMBO J. 15:1021-1027.
30. Lawrence, H. J., S. Rozenfeld, C. Cruz, K. Matsukuma, A. Kwong, L. Komuves, A. M. Buchberg, and C. Largman. 1999. Frequent co-expression of the HOXA9 and MEISI homeobox genes in human myeloid leukemias. Leukemia. 13:1993-1999.
31. Monica, K., D. P. LeBrun, D. A. Dedera, R. Brown, and M. L. Cleary. 1994. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbxl homeodomain is dispensable. Mol. Cell. Biol. 14:8304-8314.
32. Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky, B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, and et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med 180:1955-1960.
33. Peters, D. G., K. M. Klucher, R. C. Perlingeiro, S. K. Dessain, E. Y. Koh, and G. Q. Daley. 2001. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice. Oncogene 20:2636-2646.
34. Pui, J. C., D. Allman, L. Xu, S. DeRocco, F. G. Karnell, S. Bakkour, J. Y. Lee, T. Kadesch, R. R. Hardy, J. C. Aster, and W. S. Pear. 1999. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11:299-308.
35. Radtke, F., A. Wilson, G. Stark, M. Bauer, J. van Meerwijk, H. R. MacDonald, and M. Aguet. 1999. Deficient T-cell fate specification in mice with an induced inactivation of Notch1. Immunity 10:547-558.
36. Rivera, R., and C. Murre. 2001. The regulation and function of the Id proteins in lymphocyte development. Oncogene 20:8308-8316.
37. Scott, M. L., R. A. Van Etten, G. Q. Daley, and D. Baltimore. 1991. v-abl causes hematopoietic disease distinct from that caused by bcr-abl. Proc. Natl. Acad. Sci. 88:6506-6510.
38. Smith, K. S., J. W. Rhee, L. Naumovski, and M. L. Cleary. 1999. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Mol. Cell. Biol. 19:4443-4451.
39. Stier, S., T. Cheng, D. Dombkowski, N. Carlesso, and D. T. Scadden. 2002. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 99:2369-2378.
40. a. Sykes, D. B., J. Scheele, M. Pasillas, and M. P. Kamps. 2003. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-l'bx1 oncoprotein. Leukemia Lymphoma 44:1187-1199.
41. Sykes, D. B., and M. P. Kamps. 2001. Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins. Blood 98:2308-2318.
42. Takeuchi, A., S. Yamasaki, K. Takase, F. Nakatsu, H. Arase, M. Onodera, and T. Saito. 2001. E2A and HEB activate the pre-T-cell receptor alpha promoter during immature T-cell development. J. Immunol. 167:2157-2163.
43. Ting, C. N., M. C. Olson, K. P. Barton, and J. M. Leiden. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384:474-478.
44. Troussard, X., R. Rimokh, F. Valensi, D. Leboeuf, O. Fenneteau, A. M. Guitard, A. M. Manel, F. Schillinger, C. Leglise, A. Brizard, and et al. 1995. Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group. Br. J. Haematol. 89:516-526.
45. Tsai, S., S. Bartelmez, E. Sitnicka, and S. Collins. 1994. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev. 8:2831-2841.
46. van de Wetering, M., M. Oosterwegel, D. Dooijes, and H. Clevers. 1991. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J. 10:123-132.
47. Van Etten, R. A. 2001. Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models. Curr. Opin. Hematol. 8:224-230.
48. van Noort, M., and H. Clevers. 2002. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev. Biol. 244:1-8.
49. Wong, P. M., X. D. Han, F. W. Ruscetti, and S. W. Chung. 1994. Immortalized hemopoietic cells with stem cell properties. Immunity 1:571-583.
50. Zhang, X., and R. Ren. 1998. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess IL-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 92:3829-3840.